Federal Register of Legislation - Australian Government

Primary content

PB 69 of 2008 Determinations/Health as made
This Determination amends National Health Act 1953 - Determination under section 84AH - Exempt items (No. PB 58 of 2007).
Administered by: Health
Registered 10 Jun 2008
Tabling HistoryDate
Tabled HR16-Jun-2008
Tabled Senate16-Jun-2008
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

 

COMMONWEALTH OF AUSTRALIA

 

Instrument number PB 69 of 2008

Amendment determination under section 84AH of the National Health Act 1953

 

 

I, ANDREW MITCHELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing make this instrument under section 84AH of the National Health Act 1953.

Dated 3 JUNE 2008

 

 

ANDREW MITCHELL

Acting Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

 

 

 

 

Amendment determination – exempt items

 

 

1            Commencement

 

This instrument commences on 1 July 2008.

 

 

2           Amendment of PB 58 of 2007

 

                             Schedule 1 amends PB 58 of 2007.

         


Schedule 1                                Amendments

 

 

[1]     Schedule 1, item dealing with Baclofen

                  

omit from the columns in the order indicated:

 

Baclofen

Injection 10 mg in 5 mL

Injection

Baclofen

Injection 10 mg in 20 mL

Injection

 

[2]     Schedule 1, item dealing with Cyclosporin

 

omit from the columns in the order indicated:

 

Cyclosporin

Solution concentrate for intravenous infusion 250 mg in 5 mL

Injection

 

 

 

 

 

[3]     Schedule 1, item dealing with Hydrocortisone

                  

omit from the columns in the order indicated:

 

Hydrocortisone

Injection 100 mg (as sodium succinate)

Injection

Hydrocortisone

Injection 250 mg (as sodium succinate)

Injection

 

 

 

 

 

 

 

 

[4]     Schedule 1, after item dealing with Lansoprazole

 

                   insert in the columns in the order indicated:

 

Levodopa with Carbidopa

Tablet 200 mg-50 mg (anhydrous) (modified release) 

Oral

 

 

 

 

 

 

 

 

                                                     

 

 

 

 

 

[5]     Schedule 1, item dealing with Metronidazole

 

                   omit from the columns in the order indicated:

 

Metronidazole

Solution for intravenous infusion 500 mg in 100 mL

Injection

 

 

[6]     Schedule 1, item dealing with Octreotide

 

                   omit from the columns in the order indicated:

 

Octreotide

Injection (modified release) 10 mg (as acetate) vial and diluent syringe

Injection

Octreotide

Injection (modified release) 20 mg (as acetate) vial and diluent syringe

Injection

Octreotide

Injection (modified release) 30 mg (as acetate) vial and diluent syringe

Injection

 

 

         [7]     Schedule 1, after item dealing with Salbutamol, Oral solution 2 mg

          (as sulfate) per 5 mL, 150 mL

 

                   insert in the columns in the order indicated:

 

Salbutamol

Pressurised inhalation in breath actuated device 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation)

Inhalation by mouth